Form 4 Tracker
James Woodruff Lillie

Chief Scientific Officer · 7 filings · Latest: Aug 3, 2026

MapLight Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MPLT
James Woodruff LillieChief Scientific OfficerAug 3, 2026
Sale
$12.5422,082$276.9K202,380
MPLT
Lillie James WoodruffAug 3, 2026
Proposed Sale
$13.0222,082$287.5K
MPLT
James Woodruff LillieChief Scientific OfficerJul 17, 2026
Sale
$37.902,077$78.7K224,462
MPLT
James Woodruff LillieChief Scientific OfficerJul 16, 2026
Sale
$36.798,547$314.4K226,539
MPLT
James Woodruff LillieChief Scientific OfficerJul 15, 2026
Sale
$36.707,643$280.5K235,086
MPLT
Lillie James WoodruffJul 15, 2026
Proposed Sale
$37.9118,835$714.0K
MPLT
James Woodruff LillieChief Scientific OfficerMay 7, 2026
Sale
$28.28721$20.4K242,729
MPLT
James Woodruff LillieChief Scientific OfficerMay 6, 2026
Sale
$28.7624,811$713.6K243,450
MPLT
James Woodruff LillieChief Scientific OfficerMay 5, 2026
Sale
$28.2011,095$312.8K268,261
MPLT
James Woodruff LillieChief Scientific OfficerMay 4, 2026
Sale
$27.9615,801$441.8K279,356
MPLT
Lillie James WoodruffMay 4, 2026
Proposed Sale
$30.7052,428$1.6M
MPLT
James Woodruff LillieChief Scientific OfficerApr 16, 2026
Sale
$27.372,783$76.2K295,157
MPLT
James Woodruff LillieChief Scientific OfficerApr 15, 2026
Sale
$26.821,730$46.4K297,940
MPLT
Lillie James WoodruffApr 15, 2026
Proposed Sale
$27.024,896$132.3K
MPLT
Lillie James WoodruffApr 15, 2026
Proposed Sale
$27.024,896$132.3K